03:54:05 EST Wed 01 Dec 2021
Enter Symbol
or Name

Login ID:
Aurora Cannabis Inc (2)
Symbol ACB
Shares Issued 141,282,931
Close 2020-12-17 C$ 12.35
Recent Sedar Documents

Globe says analyst has some concerns with Aurora

2020-12-18 07:14 ET - In the News

The Globe and Mail reports in its Friday, Dec. 18, edition that Desjardins Securities analyst John Chu has increasing concerns about the ability of Aurora Cannabis's ($12.35) Aurora Sky facility to produce the premium flower expected from management. The Globe's David Leeder writes in the Eye On Equities column that though Mr. Chu thinks the Edmonton-based company's revised covenant provides additional flexibility and its decision to cut capacity and costs "should help keep the company on its path to positive EBITDA (albeit later than expected)." He thinks the output at its flagship facility is "the biggest unknown and risk factor." After trimming his earnings outlook to reflect "a slower path" to positive earnings before interest, taxes, depreciation and amortization, which he now expects in the fourth quarter of 2021, Mr. Chu lowered his target for Aurora shares to $12 from $13 with an unchanged "hold" recommendation. Analysts on average target the shares at $10.45. The Globe reported on Nov. 18 that ATB Capital Markets analyst David Kideckel had upgraded Aurora Cannabis to "sector perform" from "underperform." The shares could then be had for $9.40.

© 2021 Canjex Publishing Ltd. All rights reserved.